Neumora Therapeutics Inc (NMRA)

03:48 AM

Can Neumora Therapeutics Inc. stock maintain growth trajectory2025 Top Decliners & Long-Term Safe Investment Plans - newser.com

03:48 AM

Nov 03, 2025

How moving averages guide Neumora Therapeutics Inc. tradingPortfolio Profit Report & Safe Capital Growth Tips - newser.com

Nov 03, 2025

Nov 03, 2025

Neumora Therapeutics accelerates investor outreach in Boston and New York - Traders Union

Nov 03, 2025

Nov 03, 2025

Neumora Therapeutics to Participate in Upcoming Conferences in November - The Manila Times

Nov 03, 2025

Nov 03, 2025

Real time social sentiment graph for Neumora Therapeutics Inc.Weekly Stock Analysis & Capital Efficiency Focused Ideas - newser.com

Nov 03, 2025

Nov 03, 2025

Neumora (Nasdaq: NMRA) to participate in two November conferences; webcasts available - Stock Titan

Nov 03, 2025

Nov 03, 2025

Heatmap analysis for Neumora Therapeutics Inc. and competitors2025 Investor Takeaways & Daily Price Action Insights - newser.com

Nov 03, 2025

Nov 03, 2025

Why Neumora Therapeutics Inc. stock is a must watch in 20252025 Valuation Update & Growth-Oriented Investment Plans - newser.com

Nov 03, 2025

Nov 02, 2025

Can a trend reversal in Neumora Therapeutics Inc. lead to recoveryPortfolio Performance Report & Daily Volume Surge Signals - newser.com

Nov 02, 2025

Nov 02, 2025

Is Neumora Therapeutics Inc. stock a safe investment in uncertain marketsJuly 2025 EndofMonth & Reliable Price Breakout Alerts - newser.com

Nov 02, 2025

Nov 02, 2025

What risks investors should watch in Neumora Therapeutics Inc. stockEarnings Overview Report & Daily Technical Stock Forecast Reports - newser.com

Nov 02, 2025

Nov 01, 2025

Neumora Therapeutics, Inc. (NMRA) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK

Nov 01, 2025

Nov 01, 2025

Is Neumora Therapeutics Inc. stock entering bullish territoryJuly 2025 Review & Long Hold Capital Preservation Plans - newser.com

Nov 01, 2025

Nov 01, 2025

Will Neumora Therapeutics’ (NMRA) Novel Drug Pipeline Define Its Competitive Edge in Biotech? - Sahm

Nov 01, 2025

Nov 01, 2025

What momentum shifts mean for Neumora Therapeutics Inc.July 2025 WrapUp & Expert Curated Trade Setup Alerts - newser.com

Nov 01, 2025

Oct 31, 2025

Neumora Therapeutics’ Experimental Drug Demonstrates Weight Loss in Preclinical Studies - MSN

Oct 31, 2025

Oct 31, 2025

Regression analysis insights on Neumora Therapeutics Inc. performance2025 Year in Review & Daily Profit Maximizing Tips - newser.com

Oct 31, 2025

Oct 31, 2025

Neumora Therapeutics Inc. stock outlook for YEARJuly 2025 Review & Free Safe Capital Growth Stock Tips - newser.com

Oct 31, 2025

Oct 31, 2025

Published on: 2025-10-31 04:44:03 - newser.com

Oct 31, 2025

Oct 31, 2025

Published on: 2025-10-31 03:53:08 - newser.com

Oct 31, 2025

Oct 31, 2025

Neumora Therapeutics, Inc. (NMRA) stock price, news, quote and history - Yahoo! Finance UK

Oct 31, 2025

Oct 31, 2025

Neumora Therapeutics (NMRA): Evaluating Valuation Following Dual Pipeline Advances in Psychiatry and Obesity - Yahoo Finance

Oct 31, 2025

Oct 30, 2025

Needham Lifts PT on Neumora Therapeutics (NMRA) to $8 From $6, Keeps a Buy Rating - Insider Monkey

Oct 30, 2025

Oct 30, 2025

Arch Venture Partners Xii, Llc Acquires 1,915,700 Shares of Neumora Therapeutics (NASDAQ:NMRA) Stock - MarketBeat

Oct 30, 2025

Oct 30, 2025

Neumora Therapeutics (NASDAQ:NMRA) Director Kristina Burow Acquires 1,915,700 Shares - MarketBeat

Oct 30, 2025

Oct 30, 2025

Neumora Therapeutics Stock (NMRA) Opinions on Obesity Drug Data Release - Quiver Quantitative

Oct 30, 2025

Oct 30, 2025

Neumora Therapeutics’ Phase 3 Study on NMRA-335140: A Potential Breakthrough for Major Depressive Disorder - MSN

Oct 30, 2025

Oct 30, 2025

Neumora Therapeutics’ Phase 3 Study on NMRA-335140: A Potential Game-Changer for Depression Treatment - MSN

Oct 30, 2025

Oct 30, 2025

Guggenheim upgrades Neumora Therapeutics, Inc. (NMRA) to a Buy - The Globe and Mail

Oct 30, 2025

Oct 30, 2025

Neumora Therapeutics Advances MDD Treatment with Long-term Study - MSN

Oct 30, 2025

Oct 30, 2025

Neumora to initiate phase 1 study of oral obesity pill - MSN

Oct 30, 2025

Oct 30, 2025

Neumora Therapeutics Insider Bought Shares Worth $4,999,977, According to a Recent SEC Filing - MarketScreener

Oct 30, 2025

Oct 30, 2025

Neumora Therapeutics price target raised to $8 from $6 at Needham - MSN

Oct 30, 2025

Oct 30, 2025

Published on: 2025-10-30 01:21:45 - newser.com

Oct 30, 2025

Oct 29, 2025

Major Stakeholders Make Bold Moves in Neumora Therapeutics! - TipRanks

Oct 29, 2025

Oct 29, 2025

[Form 4] Neumora Therapeutics, Inc. Insider Trading Activity - Stock Titan

Oct 29, 2025

Oct 29, 2025

Neumora Therapeutics (NASDAQ:NMRA) Price Target Raised to $8.00 - MarketBeat

Oct 29, 2025

Oct 29, 2025

Neumora Therapeutics, Inc. (NASDAQ:NMRA) Given Consensus Rating of "Hold" by Analysts - MarketBeat

Oct 29, 2025

Oct 29, 2025

Is Neumora Therapeutics Inc. stock a top pick in earnings season2025 Buyback Activity & Safe Entry Zone Tips - fcp.pa.gov.br

Oct 29, 2025

Oct 29, 2025

Neumora Therapeutics’ NMRA-323511 Study: A Potential Breakthrough in Alzheimer’s Treatment - MSN

Oct 29, 2025

Oct 28, 2025

14 Stocks Under $5 with Highest Upside Potential - Insider Monkey

Oct 28, 2025

Oct 28, 2025

Needham Maintains Neumora Therapeutics (NMRA) Buy Recommendation - MSN

Oct 28, 2025

Oct 28, 2025

A Quick Look at Today's Ratings for Neumora Therapeutics(NMRA.US), With a Forecast Between $5 to $18 - 富途牛牛

Oct 28, 2025